(Q41696468)

7 October 2017

1 reference

title

Low-dose corticosteroid therapy in rheumatoid arthritis: balancing the evidence (English)

1 reference

7 October 2017

1 reference

K G Saag

1

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

American Journal of Medicine

7 October 2017

published in

1 reference

7 October 2017

volume

103

1 reference

7 October 2017

issue

6A

1 reference

7 October 2017

page(s)

31S-39S

1 reference

Corticosteroids in rheumatoid arthritis

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Corticosteroid therapy in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Variation among rheumatologists in the use of prednisone and second-line agents for the treatment of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Long-term study of management of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

A method for assessing the quality of a randomized control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

EMPIRE Rheumatism Council; multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results up to one year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. A second report by the joint committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, ACTH, and other t

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Glucocorticoids and Joint Destruction in Rheumatoid Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Long-term outcome of treating rheumatoid arthritis: results after 20 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

The mortality of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

The relative toxicity of disease-modifying antirheumatic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Long term (five or more years) administration of corticosteroids in pulmonary diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Conversion from daily to alternate daily corticosteroids in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Psychiatric side effects of steroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Corticosteroid osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Bone loss after glucocorticoid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Axial bone density in rheumatoid arthritis: comparison of dual-energy projection radiography and dual-photon absorptiometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Biological markers in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Determining causation--a case study: adrenocorticosteroids and osteoporosis. Should the fear of inducing clinically important osteoporosis influence the decision to prescribe adrenocorticosteroids?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Generalised bone loss in patients with early rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Rheumatoid arthritis, corticosteroid therapy and hip fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

The systemic effect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Major undesirable side-effects resulting from prednisolone and prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Association of Adrenocorticosteroid Therapy and Peptic-Ulcer Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Glucocorticosteroid therapy: mechanisms of action and clinical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Risk of infectious complications in patients taking glucocorticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Bacteriuria in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Use of inhaled corticosteroids and the risk of cataracts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Effect of corticosteroids on cataract formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Ocular complications in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Steroid-induced diabetic ketoacidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Pituitary adrenal recovery following short-term suppression with corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Pituitary adrenal function during corticosteroid withdrawal in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

On the various forms of corticosteroid withdrawal syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Complications of long-term steroid therapy for asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Does long-term low-dose corticosteroid therapy cause hypertension?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990006-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(97)90006-1

1 reference

7 October 2017

1 reference